Healthera, a Cambridge-based digital health platform has closed a £3m Series A, led by ADV with participation from Cambridge Enterprise.
The startup connects patients to a network of NHS GPs, allowing them to order and track their prescriptions, access clinical services, and monitor their medication intake in one digital end-to-end solution.
Healthera was co-founded in 2015 by three University of Cambridge alumni Quintus Liu, Martin Hao and Jin Dai, during their last year of study.
Soon after its inception, the startup raised pre-Seed funding and was incubated by Silicon Valley entrepreneurs through Founder.org.
Healthera later raised a Seed round from Cambridge Enterprise.
Commenting on the news, Liu, the CEO at Healthera, said: “Over the past months, Healthera’s platform has won the confidence of the market as shown by the speed of adoption among patients, healthcare professionals, and NHS organisations.
UK tech sector growth weakest for three years
“With this investment led by keystone investors ADV, Cambridge Enterprise, and Future Care Capital, we will be accelerating our expansion into every household, and soon, multiple healthcare verticals.”
Since commercially launching late last year, Healthera claims to connect more than 500 pharmacies and GPs, tens of thousands of patients, and is partnering with NHS local authorities (CCG).
Its app is listed on the NHS Digital apps library, and has an ongoing NHS-funded patient benefit research with Institute of Public Health, University of Cambridge.
Mike Dimelow, chief investment officer at ADV, added: “Repeat medical prescriptions are used by millions in the UK each year and many more across the world. Paperwork, physical appointments and lack of focus on patient’s needs make this an all too often inefficient process for all involved.
“Healthera is tackling this by bringing clinical services, prescription and medicine intake monitoring in one consumer platform which has seen rapid uptake from pharmacists and patients since launching in Q4 2017. We expect to see this user base grow even more rapidly as the team expands across the UK and beyond towards a time of effortless prescription for those in need.”